文献速递间质性肺疾病

肺纤维化与TERT奠基突变:潜伏期长达300年

Pulmonary Fibrosis and a TERT Founder Mutation With a Latency Period of 300 Years.
PubMed 文献 · Chest · 2020-04-19

本研究对家族性肺纤维化患者进行TERT基因筛查,发现TERT c.2005T突变在1255例肺纤维化患者中检出13例,而在ILD无肺纤维化患者和健康对照中均未检出。家系研究将4例携带者追溯至7代前共同祖先,跨度300年,提示端粒缩短累积效应可经超长潜伏期导致肺纤维化。

要点

  • TERT c.2005T为致病突变,与肺纤维化相关。
  • 该突变携带者肺纤维化潜伏期可超过300年。
  • 临床解读TERT突变需多学科讨论,关注遗传早现。

核心结论

  • TERT c.2005T突变是致病突变,与肺纤维化相关,其累积效应可经超过300年潜伏期才导致疾病。

研究设计与样本

  • 对240例家族性肺纤维化患者筛查TERT基因,并对1015例肺纤维化、1237例无肺纤维化的ILD患者和529例健康对照进行TERT c.2005C>T基因分型。
  • 对所有携带TERT c.2005T突变的患者进行家谱研究。

主要发现

  • 在1255例肺纤维化患者中检出13例TERT c.2005T(p.Arg669Trp)突变,而无肺纤维化的ILD患者和健康对照中均未检出。
  • 家谱研究将4例TERT c.2005T突变携带者联系到7代前共同祖先,跨度300年。

临床怎么用

  • 临床解读TERT突变时需考虑遗传早现现象,疾病与遗传早现结果相关而非仅突变存在。
  • 推荐肺科医师、临床遗传学家和遗传实验室专家进行多学科讨论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Germline mutations in the gene encoding TERT cause haploinsufficiency with subsequent telomere shortening. TERT mutations are associated with short telomere syndromes, such as pulmonary fibrosis (PF), which is often the first manifestation of a short telomere syndrome. Telomere length is heritable, and progeny of telomerase mutation carriers are known to have shorter telomeres. In families with TERT mutations, genetic anticipation, the earlier onset of symptoms with successive generation, is described. Little is known on the number of generations that may pass before disease occurs in families with a TERT mutation. RESEARCH QUESTION: The objective of this study was to determine classification and origin of the new TERT c.2005T mutation from population genetics and genealogic data and disease history of affected families. STUDY DESIGN AND METHODS: The TERT gene of 240 patients with familial PF was screened for mutations. Additionally, 1,015 patients with PF, 1,237 patients with an interstitial lung disease (ILD) without PF, and 529 healthy control subjects were genotyped for the TERT c.2005C>T mutation. Genealogic research was performed on all patients who carried the TERT c.2005T mutation. RESULTS: We detected the TERT c.2005T (p.Arg669Trp) mutation in 13 out of 1,255 patients with PF vs none of the patients with ILD without PF and the healthy control subjects. Genealogic research connected four of the TERT c.2005T mutation carriers to a common ancestor who lived seven generations back, spanning a period of 300 years. INTERPRETATION: The TERT c.2005T mutation is a pathogenic mutation and associates with PF. This study learns that a latency period of > 300 years may pass before the cumulative effect of telomere shortening eventually leads to PF. This finding underlines the complexity of the clinical interpretation of TERT mutations because, not the presence of the mutation, but the result of genetic anticipation, is associated with disease. Therefore, multidisciplinary discussion between pulmonary physicians, clinical geneticists, and genetic laboratory experts is recommended.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. van der Vis JJ, van der Smagt JJ, Hennekam FAM, et al. Pulmonary Fibrosis and a TERT Founder Mutation With a Latency Period of 300 Years. Chest. 2020. PMID: 32315675. doi:10.1016/j.chest.2020.03.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。